General Healthcare News
Agency holds off decision on expanding use of shot to 12-to-17-year-olds while it looks into risk of rare heart condition The Food and Drug Administration is delaying a decision on authorizing Moderna Inc.’s Covid-19 vaccine for...
By Tilyona Trefethen People often ask me: "What does it take to implement Digital Pathology?" My immediate reaction: "It takes vision. Buy-in. Planning. And execution. Like last year's NFL campaign slogan says, it takes all of us,...
Exclusive: combination of drugs causes tumours to vanish in some terminally ill patients, study finds A new cancer treatment can wipe out tumours in terminally ill head and neck cancer patients, scientists have discovered. In a landmark...
The Covid-19 treatment molnupiravir was developed using funding from the National Institutes of Health and the Department of Defense. A FIVE-DAY COURSE of molnupiravir, the new medicine being hailed as a “huge advance” in the treatment of...
At the Interim Analysis, 7.3 Percent of Patients Who Received Molnupiravir Were Hospitalized Through Day 29, Compared With 14.1 Percent of Placebo-Treated Patients Who were Hospitalized or Died Merck Plans to Seek Emergency Use Authorization...
(RTTNews) - As we head into the fourth quarter of 2021, here is a recap of what happened on the regulatory front this month that caught our attention. Samsung Bioepis' Byooviz became the first biosimilar for Lucentis to treat macular...
